Skip to main content
GMED logo

GMED · Globus Medical Inc · Executive Compensation

Track GMED — free
$83.08 +1.82 (+2.24%) Q2 2026 earnings call transcript
Market Cap
$10.91B
Shares
134.26M
Volume · Oct 29 473.9K Avg daily vol (3M) 1.4M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Daniel T. Scavilla $5,316,939
Keith W. Pfeil $4,400,159
David C. Paul $4,305,179
Kelly Huller $2,280,832
Kyle R. Kline $1,380,258
Fiscal 2024
Executive Total
Daniel T. Scavilla $4,858,660
David C. Paul $3,059,800
Keith W. Pfeil $2,363,278
Kelly Huller $1,628,623
Fiscal 2023
Executive Total
Daniel T. Scavilla $4,564,374
David C. Paul $3,221,696
Keith W. Pfeil $2,063,448
Keith Pfeil $2,063,448
Kelly Huller $1,639,948
Fiscal 2022
Executive Total
David Demski $4,737,281
Daniel T. Scavilla $3,818,318
David C. Paul $2,612,849
Keith W. Pfeil $1,487,463
Keith Pfeil $1,487,463
Kelly Huller $1,151,917
Fiscal 2021
Executive Total
David Demski $5,088,592
David C. Paul $1,965,206
Daniel T. Scavilla $1,935,989
Keith Pfeil $1,400,060
Kelly Huller $1,125,505
Fiscal 2020
Executive Total
David Demski $4,026,977
David C. Paul $2,420,001
Daniel T. Scavilla $2,028,387
Keith Pfeil $1,201,841
Kelly Huller $1,086,235
Fiscal 2019
Executive Total
David Demski $3,449,794
David C. Paul $2,274,285
Daniel T. Scavilla $1,905,544
Anthony L. Williams $1,460,242
Kelly Huller $1,120,965
Keith Pfeil $787,667
Fiscal 2018
Executive Total
David Demski $3,394,012
David C. Paul $2,246,643
Daniel T. Scavilla $1,879,563
Anthony L. Williams $1,870,473
Fiscal 2017
Executive Total
David Demski $4,451,524
David C. Paul $2,300,160
Anthony L. Williams $1,438,263
Daniel T. Scavilla $1,311,875

Executive changes

Person Change Filed
Robert A. Douglas Appointed 2026-06-04
Keith W. Pfeil Appointed 2026-06-04
John A. DeFord, Ph.D. Resigned 2026-03-23
Keith W. Pfeil Appointed 2025-07-21
Keith W. Pfeil Appointed 2025-07-21
Kyle Kline Appointed 2025-07-21
Daniel T. Scavilla Resigned 2025-07-21
Daniel T. Scavilla Resigned 2025-07-21
Leslie V. Norwalk, Esq. Appointed 2025-06-05
Ann D. Rhoads Appointed 2025-06-05
Daniel T. Lemaitre Appointed 2025-06-05
David C. Paul Appointed 2025-06-05
Stephen T. Zarrilli Appointed 2024-06-06
Daniel J. Wolterman Appointed 2024-06-06
James R. Tobin Appointed 2024-06-06
David D. Davidar Appointed 2024-06-06
Keith Pfeil Appointed 2024-02-05
Daniel J. Wolterman Appointed 2023-09-01
John A. DeFord Appointed 2023-09-01
Leslie V. Norwalk Appointed 2023-09-01
Robert A. Douglas Appointed 2023-06-08
Daniel T. Scavilla Appointed 2023-06-08

Leadership

Key facts CIK 1237831 CUSIP 379577208 13F (30d) 170 filings 163 filers Visit website Investor relations